Danish Centre for Strategic Research in Type 2 Diabetes

The Danish Center for Strategic Research in Type II Diabetes (DD2) aims to improve treatment and long-term outcomes of patients with newly diagnosed type 2 diabetes (T2D). The overall goal is to near-normalize metabolic control in patients, using an individualized treatment approach. The biobank includes samples from 50,000 patients with newly diagnosed T2D.

Key facts

Name of the connected EIT Health partner:Lasse Boding
Number of individuals:Total 6,482
Biobank confirmed willingness to provide samples/data for EIT Health studies:Yes
Contact person(s) and contact data
(e-mail address, tel. no) for access purposes:
Program leader and Associate Professor Jens Steen Nielsen, Kloevervaenget 10. 9th floor, 5000 Odense C, T:+45 21609032, E: jsn@rsyd.dk
Number of samples:Total 7,507
Omics data:No
Website:Danish Center for Strategic Research in Type II Diabetes (DD2)

General information

Type of biobank:Prospective, newly diagnosed type 2 diabetes.
If longitudinal the frequency:Selected cohorts have repeated samples, longitudinal with up to 12 years of repeated sampling.
Link to central portal to seek samples and data:www.dd2.nu
and Danish Biobank Register www.biobanks.dk
Broad consent:Yes
https://dd2.structtest.dk/media/1315/dd2-deltagerinformation-januar-2019.pdf  https://dd2.structtest.dk/media/1314/dd2-samtykkeerklaering.pdf
Option to recall donors:Yes.
Option to recall family members:Maybe.

Biobank access procedure:

Major terms for access:https://dd2.nu/media/1264/standard-dd2-protocol_final.doc
Ethical and legal compliance:Required
Speed and reliability of delivery:Depends on approval
Pricing:Depends on the type of project collaboration vs. industrial

Quality management system:

Link to operational procedures:Link 1, Link 2
Storage:-80 degrees Celcius.
Compliance with international standards:Not available.
Current ISO certificates:Not available.


Clinical data linked to samples:Yes, a broad number of Danish health care registries.
Data standards:Not available.
Data security rules:Danish GDPR standards.

Biobank related service:

Research support, what type of expertise?:Epidemiology and statistical support.
Core facility services; what type? Link?:Biobank, data-manager.
Queries from national health registers:Yes.


IP rules, what is negotiable?:Required MTA, scientific contract, data processor agreement.
Requirements to study results (access etc.):Can be partially granted.
Participant’s right to the information:Not available.
Number of access contracts with industry:1-3

The "Registers and Biobanks in Transition” strategic initiative is funded by EIT Health